ANGO
Price
$12.04
Change
+$0.15 (+1.26%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
491.44M
77 days until earnings call
Intraday BUY SELL Signals
SOLV
Price
$87.49
Change
+$0.82 (+0.95%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
14.75B
14 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ANGO vs SOLV

ANGO vs SOLV Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ANGO vs. SOLV commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANGO is a Hold and SOLV is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ANGO with price predictions
Oct 21, 2026

ANGO in upward trend: price expected to rise as it breaks its lower Bollinger Band on October 06, 2026

ANGO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 29 of 33 cases where ANGO's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 88%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ANGO's RSI Indicator exited the oversold zone, 24 of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 80%.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +4.39% 3-day Advance, the price is estimated to grow further. Considering data from situations where ANGO advanced for three days, in 197 of 269 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ANGO as a result. In 65 of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 71%.

ANGO moved below its 50-day moving average on October 06, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ANGO crossed bearishly below the 50-day moving average on October 05, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 15 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 88%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ANGO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.

The Aroon Indicator for ANGO entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 18 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.877) is normal, around the industry mean (4.952). P/E Ratio (-13.511) is within average values for comparable stocks, (36.644). Projected Growth (PEG Ratio) (0.110) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (2.005) is also within normal values, averaging (56.876).

The Tickeron PE Growth Rating for this company is 26 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating fairly steady price growth. ANGO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ANGO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

A.I.Advisor
a Summary for SOLV with price predictions
Oct 21, 2026

SOLV's RSI Indicator recovers from oversold territory

The RSI Indicator for SOLV moved out of oversold territory on October 08, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 19 similar instances when the indicator left oversold territory. In 15 of the 19 cases the stock moved higher. This puts the odds of a move higher at 79%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 23 of 30 cases where SOLV's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 77%.

The Momentum Indicator moved above the 0 level on October 21, 2026. You may want to consider a long position or call options on SOLV as a result. In 31 of 45 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 69%.

Following a +1.91% 3-day Advance, the price is estimated to grow further. Considering data from situations where SOLV advanced for three days, in 99 of 149 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.

SOLV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

SOLV moved below its 50-day moving average on October 01, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for SOLV crossed bearishly below the 50-day moving average on October 06, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 4 of 7 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 57%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SOLV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 59%.

The Aroon Indicator for SOLV entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 30 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. SOLV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 63 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.074) is normal, around the industry mean (4.952). P/E Ratio (10.531) is within average values for comparable stocks, (36.644). Projected Growth (PEG Ratio) (1.220) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (1.871) is also within normal values, averaging (56.876).

The Tickeron PE Growth Rating for this company is 94 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SOLV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

FUNDAMENTALS RATINGS
ANGO: Fundamental Ratings
ANGO
OUTLOOK RATING
1..100
77
VALUATION
overvalued / fair valued / undervalued
1..100
18
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
26
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANGOSOLV
RSI
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
71%
Bullish Trend 2 days ago
69%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
57%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
64%
Advances
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
66%
Declines
ODDS (%)
Bearish Trend 10 days ago
72%
Bearish Trend 4 days ago
59%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
64%
Aroon
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
53%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (ANGO: $11.89 vs. SOLV: $86.67)
Brand notoriety: ANGO and SOLV are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ANGO: 106% vs. SOLV: 86%
Market capitalization -- ANGO: $496.82M vs. SOLV: $14.75B
ANGO [@Pharmaceuticals: Other] is valued at $496.82M. SOLV’s [@Pharmaceuticals: Other] market capitalization is $14.75B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $156.8B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $9.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANGO’s FA Score shows that 2 FA rating(s) are green while SOLV’s FA Score has 1 green FA rating(s).

  • ANGO’s FA Score: 2 green, 3 red.
  • SOLV’s FA Score: 1 green, 4 red.
According to our system of comparison, both ANGO and SOLV are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANGO’s TA Score shows that 4 TA indicator(s) are bullish while SOLV’s TA Score has 5 bullish TA indicator(s).

  • ANGO’s TA Score: 4 bullish, 5 bearish.
  • SOLV’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, SOLV is a better buy in the short-term than ANGO.

Price Growth

ANGO (@Pharmaceuticals: Other) experienced а +7.60% price change this week, while SOLV (@Pharmaceuticals: Other) price change was -0.68% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.74%. For the same industry, the average monthly price growth was -3.62%, and the average quarterly price growth was +9.09%.

Reported Earning Dates

ANGO is expected to report earnings on Jan 07, 2027.

SOLV is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (+0.74% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

View a ticker or compare two or three
ANGO
Daily Signal:
Gain/Loss:
SOLV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

ANGO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANGO has been loosely correlated with STRRP. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ANGO jumps, then STRRP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANGO
1D Price
Change %
ANGO100%
+0.68%
STRRP - ANGO
48%
Loosely correlated
-2.43%
BLCO - ANGO
38%
Loosely correlated
+1.48%
MXCT - ANGO
36%
Loosely correlated
+2.80%
SOLV - ANGO
31%
Poorly correlated
+0.32%
ICUI - ANGO
31%
Poorly correlated
-0.15%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PUSA2.030.16
+8.56%
Powerus Corporation
ALSN110.941.28
+1.17%
Allison Transmission Holdings
FRST15.58-0.09
-0.57%
Primis Financial Corp
FCNCN22.25-0.30
-1.33%
First Citizens Bancshares Inc
CPRI15.70-0.81
-4.91%
Capri Holdings Limited